Health
Foresight Diagnostics demonstrates the benefits of PhasED-Seq technology at the ICML meeting – News-Medical.Net – Fior Reports
Foresight Diagnostics, the emerging leader in the monitoring of blood-based lymphoma diseases, announced today that the clinical…
Foresight Diagnostics, the emerging leader in the monitoring of blood-based lymphoma diseases, announced today that the clinical performance of its Minimal Residual Disease Detection Platform (MRD) in Diffuse B-Cell Large Cell Lymphoma (DLBCL) will be presented…
Continue Reading
-
Business18 hours agoWhy did this ASX 200 healthcare stock crash 14% yesterday?
-
Business21 hours agoOwn Xero shares? Here are 3 key takeaways from its AGM
-
Business17 hours agoHere’s what analysts expect for the BHP share price in the coming year
-
General10 hours agoVictorian school teacher charged with soliciting child abuse material